The rising incorporation of subcutaneous immunoglobulin in ... got FDA clearance in July 2021 for Octagam 10%, its first intravenous immunoglobulin recommended for the treatment of the immune ...

Intravenous immunoglobulin (IVIg ... These promising alternatives include: For people with immunodeficiencies, subcutaneous immunoglobulin (SCIg) may be a suitable alternative.

“Subcutaneous immunoglobulin is particularly interesting,” said Akiko Iwasaki, director of Yale’s Center for Infection & Immunity. Previous studies with intravenous immunoglobulin, or ...

“Hospitals use Intravenous Immunoglobulin (IVIG ... related disorders,” the report said. Furthermore, Subcutaneous Immunoglobulin (SCIg) is gaining traction in homecare settings, particularly ...

This article discusses the differences and similarities between nivolumab subcutaneous injections and IV infusions for RCC to help people make the most suitable decisions for their treatment.

HyQvia is the only up to once monthly (every 2, 3 or 4 weeks) immunoglobulin subcutaneous infusion ... therapy after stabilization with intravenous immunoglobulin (IVIG) to prevent relapse of ...

A first-of-its-kind clinical trial clinical trial shows that therapeutic plasma exchange (TPE) combined with intravenous ...

has approved an expanded label for XEMBIFY ®, the company’s 20% subcutaneous immunoglobulin (SCIg), to include treatment-naïve patients with primary humoral immunodeficiencies (PI).

Intravenous immunoglobulin (IVIg) treatment can help you fight off infections if you have a weakened immune system or other diseases. Some people may have IVIg instead of other medications (such ...